September 12, 2018
1153 Recent Articles
September 05, 2018
Federal Circuit Remands After Patentee Failed to Disclose Priority Application to Standards Organization
September 05, 2018
Don’t Try This at Home Boys and Girls — The TTAB is no Place for Amateurs
September 04, 2018
Doing New and Useful Things Still Isn’t Enough to Meet 35 USC §101
September 04, 2018
You Can’t Sidestep Nonappealability of Institution Decisions with Mandamus
September 04, 2018
Federal Circuit Vacates Another IPR as Time-Barred
September 04, 2018
What Has Been Served Cannot Be Unserved: §315(b) Time Bar Applies Even if the Suit is Subsequently Withdrawn
September 04, 2018
If the Drawing is Sufficient to Determine Infringement, it Complies with 35 USC §112
September 04, 2018
Change In Construction of Claims from Petition Required Board to Allow Petitioner to Respond
August 31, 2018
BioPharma Patents Quick Tips & News – January 2016 – Throwback Edition
August 23, 2018
BioPharma Patents Quick Tips & News – September 2015 – Throwback Edition
August 20, 2018
Pfizer’s Biosimilar Antitrust Lawsuit Survives Johnson & Johnson’s Motion to Dismiss
August 16, 2018
BioPharma Patents Quick Tips & News – July 2015 – Throwback Edition
August 13, 2018
Trademark Registration – A Vehicle to Protection
August 09, 2018
FDA Implements Biosimilar Action Plan to Boost Biosimilar Competition
August 09, 2018
At Risk Launch: A Hypothetical Case Study
August 08, 2018
Competitor Influence on the Conduct of the Patent Dance and Litigation
August 07, 2018
Seeking Biosimilar Market Entry When a Competitor is Pursuing Interchangeability: Factors to Consider
August 03, 2018
Undue Process: You Can Ask the USPTO to Review a Patent, but if They Blow it, You may be Powerless to Appeal
July 30, 2018